Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Keyvani

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The Journal of Pathology|March 29, 2001
CDKN2A/p16 inactivation is related to pituitary adenoma type and sizeN Seemann, D Kuhn, C Wrocklage, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 13, 2015
Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T-lymphocyte recoveryK Kerl, K Ehlert, A Brentrup, et al.
Neurology|May 12, 2004
Serum S100beta increases in marathon runners reflect extracranial release rather than glial damageM Hasselblatt, F C Mooren, N von Ahsen, et al.
American Journal of Medical Genetics|August 26, 1998
Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: clinical and neuropathological observations in a 33-year-old manK Keyvani, W Paulus, H Traupe, et al.
Clinical Neurology and Neurosurgery|March 22, 2017
Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control studyJ Becker, P A Horn, K Keyvani, et al.
Neuropathology and Applied Neurobiology|May 29, 2009
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortiumC M Monoranu, M Apfelbacher, E Grünblatt, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14M Y Deng, M Sill, D Sturm, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The Journal of Pathology|March 29, 2001
CDKN2A/p16 inactivation is related to pituitary adenoma type and sizeN Seemann, D Kuhn, C Wrocklage, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society|January 13, 2015
Cerebral toxoplasmosis in an adolescent post allogeneic hematopoietic stem cell transplantation: successful outcome by antiprotozoal chemotherapy and CD4+ T-lymphocyte recoveryK Kerl, K Ehlert, A Brentrup, et al.
Neurology|May 12, 2004
Serum S100beta increases in marathon runners reflect extracranial release rather than glial damageM Hasselblatt, F C Mooren, N von Ahsen, et al.
American Journal of Medical Genetics|August 26, 1998
Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome: clinical and neuropathological observations in a 33-year-old manK Keyvani, W Paulus, H Traupe, et al.
Clinical Neurology and Neurosurgery|March 22, 2017
Primary central nervous system vasculitis and its mimicking diseases - clinical features, outcome, comorbidities and diagnostic results - A case control studyJ Becker, P A Horn, K Keyvani, et al.
Neuropathology and Applied Neurobiology|May 29, 2009
pH measurement as quality control on human post mortem brain tissue: a study of the BrainNet Europe consortiumC M Monoranu, M Apfelbacher, E Grünblatt, et al.
Neuropathology and Applied Neurobiology|December 24, 2019
Diffuse glioneuronal tumour with oligodendroglioma-like features and nuclear clusters (DGONC) - a molecularly defined glioneuronal CNS tumour class displaying recurrent monosomy 14M Y Deng, M Sill, D Sturm, et al.
Pageof 2